Hypovitaminosis D in type 2 diabetes: Relation with features of the metabolic syndrome and glycemic control

Endocrine Research

Volumn 40, Issue 3, 2015, Pages 160-165

  Miñambres, Inka ^a,b   Sánchez Quesada, Jose Luis ^c   Vinagre, Irene ^a,b   Sánchez Hernández, Joan ^d   Urgell, Eulalia ^a   De Leiva, Alberto ^a,b,c,e   Pérez, Antonio ^a,b,c,d  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c BIOMEDICAL RESEARCH INSTITUTE SANT PAU IIB SANT PAU   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

^e BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

Author keywords

Atherogenic dyslipidemia; Glucose; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; C REACTIVE PROTEIN; CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL; 25-HYDROXYVITAMIN D; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; VITAMIN D;

ADULT; ARTICLE; BIOCHEMISTRY; BODY MASS; CLINICAL FEATURE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETIC PATIENT; DISEASE ASSOCIATION; FEMALE; GLYCEMIC CONTROL; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; VITAMIN D DEFICIENCY; AGED; ANALOGS AND DERIVATIVES; BLOOD; COMPLICATION; DIABETES MELLITUS, TYPE 2; GLUCOSE BLOOD LEVEL; METABOLISM; MIDDLE AGED;

AGED; BLOOD GLUCOSE; C-REACTIVE PROTEIN; CHOLESTEROL, VLDL; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OVERWEIGHT; TRIGLYCERIDES; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84936947404     PISSN: 07435800     EISSN: 15324206     Source Type: Journal    
DOI: 10.3109/07435800.2014.982326     Document Type: Article

References (37)

1. Wang L, Song Y, Manson JE, et al. Circulating 25-hydroxy-vitamin d and risk of cardiovascular disease: a meta-Analysis of prospective studies. Circ Cardiovasc Qual Outcomes 2012;5:819-29.
2. Pittas AG, Chung M, Trikalinos T, et al. Systematic review: Vitamin D and cardiometabolic outcomes. Ann Intern Med 2010; 152:307-14.
3. Pittas AG, Lau J, Hu FB, et al. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-Analysis. J Clin Endocrinol Metab 2007;92:2017-29.
4. Afzal S, Bojesen SE, Nordestgaard BG. Low 25-hydroxyvitamin D and risk of type 2 diabetes: a prospective cohort study and metaanalysis. Clin Chem 2013;59:381-91.
5. Ybarra J, Sanchez-Hernandez J, Gich I, et al. Unchanged hypovitaminosis D and secondary hyperparathyroidism in morbid obesity after bariatric surgery. Obes Surg 2005;15:330-5.
6. Snijder MB, van Dam RM, Visser M, et al. Adiposity in relation to vitamin D status and parathyroid hormone levels: a populationbased study in older men and women. J Clin Endocrinol Metab 2005;90:4119-23.
7. Minambres I, Sanchez-Hernandez J, Sanchez-Quesada JL, et al. The association of hypovitaminosis d with the metabolic syndrome is independent of the degree of obesity. ISRN Endocrinol 2012; 2012:691803.
8. Joergensen C, Gall MA, Schmedes A, et al. Vitamin D levels and mortality in type 2 diabetes. Diabetes Care 2010;33:2238-43.
9. Targher G, Bertolini L, Padovani R, et al. Serum 25-hydroxyvitamin D3 concentrations and carotid artery intima-media thickness among type 2 diabetic patients. Clin Endocrinol (Oxf) 2006;65: 593-7.
10. Cigolini M, Iagulli MP, Miconi V, et al. Serum 25-hydroxyvitamin D3 concentrations and prevalence of cardiovascular disease among type 2 diabetic patients. Diabetes Care 2006;29:722-4.
11. Bonakdaran S, Varasteh AR. Correlation between serum 25 hydroxy vitamin D3 and laboratory risk markers of cardiovascular diseases in type 2 diabetic patients. Saudi Med J 2009;30:509-14.
12. George PS, Pearson ER, Witham MD. Effect of vitamin D supplementation on glycaemic control and insulin resistance: a systematic review and meta-Analysis. Diabet Med 2012;29: e142-50.
13. Sanchez-Quesada JL, Vinagre I, de Juan-Franco E, et al. Effect of improving glycemic control in patients with type 2 diabetes mellitus on low-density lipoprotein size, electronegative lowdensity lipoprotein and lipoprotein-Associated phospholipase A2 distribution. Am J Cardiol 2012;110:67-71.
14. Sanchez-Quesada JL, Vinagre I, De Juan-Franco E, et al. Impact of the LDL subfraction phenotype on Lp-PLA2 distribution, LDL modification and HDL composition in type 2 diabetes. Cardiovasc Diabetol 2013;12:1-8.
15. Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004;110:227-39.
16. Wagner AM, Perez A, Zapico E, et al. Non-HDL cholesterol and apolipoprotein B in the dyslipidemic classification of type 2 diabetic patients. Diabetes Care 2003;26:2048-51.
17. Hollis BW. Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr 2005;135: 317-22.
18. Holick MF. McCollum Award Lecture, 1994: vitamin D-new horizons for the 21st century. Am J Clin Nutr 1994;60:619-30.
19. Ford ES, Ajani UA, McGuire LC, et al. Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. Diabetes Care 2005;28:1228-30.
20. Lee DM, Rutter MK, ONeill TW, et al. Vitamin D, parathyroid hormone and the metabolic syndrome in middle-Aged and older European men. Eur J Endocrinol 2009;161:947-54.
21. Parker J, Hashmi O, Dutton D, et al. Levels of vitamin D and cardiometabolic disorders: systematic review and meta-Analysis. Maturitas 2010;65:225-36.
22. Chagas CE, Borges MC, Martini LA, et al. Focus on vitamin D, inflammation and type 2 diabetes. Nutrients 2012;4:52-67.
23. Jorde R, Grimnes G. Vitamin D and metabolic health with special reference to the effect of vitamin D on serum lipids. Prog Lipid Res 2011;50:303-12.
24. Luo C, Wong J, Brown M, et al. Hypovitaminosis D in Chinese type 2 diabetes: lack of impact on clinical metabolic status and biomarkers of cellular inflammation. Diab Vasc Dis Res 2009;6: 194-9.
25. Alam U, Najam O, Al-Himdani S, et al. Marked vitamin D deficiency in patients with diabetes in the UK: ethnic and seasonal differences and an association with dyslipidaemia. Diabet Med 2012;29:1343-5.
26. Al-Daghri NM, Al-Attas OS, Alokail MS, et al. Hypovitaminosis D associations with adverse metabolic parameters are accentuated in patients with diabetes mellitus type 2: a BMI-independent role of adiponectin? J Endocrinol Invest 2013;36:1-6.
27. Hansel B, Giral P, Nobecourt E, et al. Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity. J Clin Endocrinol Metab 2004;89:4963-71.
28. Ridker PM. High-sensitivity C-reactive protein and cardiovascular risk: rationale for screening and primary prevention. Am J Cardiol 2003;92:17K-22K.
29. Calle MC, Fernandez ML. Inflammation and type 2 diabetes. Diabetes Metab 2012;38:183-91.
30. Assoumou HG, Barthelemy JC, Garet M, et al. Increased waist circumference is the component of metabolic syndrome the most strongly associated with elevated C-reactive protein in elderly. Metab Syndr Relat Disord 2011;9:281-5.
31. Yiu YF, Chan YH, Yiu KH, et al. Vitamin D deficiency is associated with depletion of circulating endothelial progenitor cells and endothelial dysfunction in patients with type 2 diabetes. J Clin Endocrinol Metab 2011;96:E830-5.
32. Nagasaka S, Murakami T, Uchikawa T, et al. Effect of glycemic control on calcium and phosphorus handling and parathyroid hormone level in patients with non-insulin-dependent diabetes mellitus. Endocr J 1995;42:377-83.
33. Sayinalp S, Gedik O, Koray Z. Increasing serum osteocalcin after glycemic control in diabetic men. Calcif Tissue Int 1995;57: 422-5.
34. Shires R, Teitelbaum SL, Bergfeld MA, et al. The effect of streptozotocin-induced chronic diabetes mellitus on bone and mineral homeostasis in the rat. J Lab Clin Med 1981;97:231-40.
35. Ishida H, Seino Y, Tsuda K, et al. Effects of streptozotocin-induced diabetes on circulating levels of vitamin D metabolites. Acta Endocrinol (Copenh) 1983;104:96-102.
36. Nyomba BL, Bouillon R, Lissens W, et al. 1, 25-Dihydroxyvitamin D and vitamin D-binding protein are both decreased in streptozotocin- diabetic rats. Endocrinology 1985;116:2483-8.
37. Polonsky WH, Fisher L, Schikman CH, et al. Structured selfmonitoring of blood glucose significantly reduces A1C levels in poorly controlled, noninsulin-treated type 2 diabetes. Diabetes Care 2011;34:262-7.